Siemens Healthineers AG
SMMNY · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.12 | 1.07 | -1.38 | 1.52 |
| FCF Yield | 2.42% | 2.95% | 1.81% | 2.85% |
| EV / EBITDA | 23.40 | 17.42 | 18.17 | 15.15 |
| Quality | ||||
| ROIC | 6.89% | 6.88% | 5.13% | 5.64% |
| Gross Margin | 38.63% | 37.87% | 35.56% | 37.47% |
| Cash Conversion Ratio | 1.44 | 1.27 | 1.20 | 1.11 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.98% | 0.99% | 6.40% | 14.51% |
| Free Cash Flow Growth | 41.03% | 82.60% | -30.84% | -33.43% |
| Safety | ||||
| Net Debt / EBITDA | 2.99 | 3.20 | 3.97 | 3.57 |
| Interest Coverage | 8.08 | 6.93 | 8.24 | 25.97 |
| Efficiency | ||||
| Inventory Turnover | 3.88 | 3.32 | 3.25 | 3.39 |
| Cash Conversion Cycle | 152.73 | 171.53 | 180.63 | 164.28 |